back to Australia directory
australia clinical guidance

ADHD

A detailed Australian summary of adhd, with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Diagnosis requires persistent developmentally inappropriate symptoms across settings, functional impairment, developmental history and evidence that onset occurred in childhood. Assess learning, autism, sleep, trauma, mood, anxiety, substances and physical health because comorbidity and mimics change formulation and treatment. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian ADHD guideline

The Bottom Line

  • Diagnosis requires persistent developmentally inappropriate symptoms across settings, functional impairment, developmental history and evidence that onset occurred in childhood.
  • Assess learning, autism, sleep, trauma, mood, anxiety, substances and physical health because comorbidity and mimics change formulation and treatment.
  • Rating scales support information gathering but cannot replace developmental history, impairment and differential diagnosis.
  • Use environmental and behavioural supports at home, study or work, with reasonable adjustments and goals defined by meaningful function.
sources for this section:Australian ADHD guideline

Practical clinical workflow

1

Topic-specific assessment action

Diagnosis requires persistent developmentally inappropriate symptoms across settings, functional impairment, developmental history and evidence that onset occurred in childhood.
2

Topic-specific diagnostic action

Use environmental and behavioural supports at home, study or work, with reasonable adjustments and goals defined by meaningful function.
3

Topic-specific management action

Medicine initiation and continuation require baseline cardiovascular and growth or weight assessment, adverse-effect monitoring and compliance with jurisdictional prescribing controls.
4

Topic-specific follow-through

For children, gather reports from both home and education and implement classroom supports even when medicine is used.
sources for this section:Australian ADHD guideline

Safety boundaries and escalation

  • Escalate suicidality, severe aggression, psychosis, mania, dangerous substance use or cardiovascular symptoms during stimulant treatment immediately.
  • Document sleep, appetite, growth or adult weight, pulse and blood pressure at each medicine review and ask about diversion.
sources for this section:Australian ADHD guideline

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian ADHD guideline

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian ADHD guideline

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australian ADHD Professionals AssociationAustralian Evidence-Based Clinical Practice Guideline for ADHD2022 NHMRC-approved guideline 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.